Document is current
Any future updates will be listed below
-
Authors
Ouedraogo, Henri Gautier http://orcid.org/0000-0001-8566-7530
Matteelli, Alberto
Sulis, Giorgia
Compaore, Tegwinde Rebeca
Diagbouga, Serge
Tiendrebeogo, Simon
Roggi, Alberto
Cisse, Kadari
Giorgetti, Pier Francesco
Villani, Paola
Sangare, Lassana
Simpore, Jacques
Regazzi, Mario
Kouanda, Seni
-
Clinical Trials BETA
Clinical trials referenced in this document:
pactr201310000629390 at Pan African Clinical Trial RegistryDocuments that mention this clinical trial
Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week
https://doi.org/10.1186/s12941-020-0345-6
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (Senior Fellowship Grant, Ref. TA.2011.40200.026)
- License Information
-
More Information
Article History
Received: 5 August 2019
Accepted: 7 January 2020
First Online: 22 January 2020
Ethics approval and consent to participate
: All participants provided written informed consent. The study received ethical approval from the national Ethics Committee for Health Research (Comité d’éthique pour la recherche en santé, CERS) of Burkina Faso.
: Not applicable.
: The authors declare that they have no competing interests.
